Retatrutide<\/strong>, also known by the research designation The material is supplied in the form of lyophilized powder and is intended for In molecular research, Retatrutide is of particular interest. The research context mentioned does not constitute a claim regarding health, Retatrutide can be used in controlled experimental conditions In terms of mechanistic research, Retatrutide is characterized Results obtained in cellular, preclinical or clinical studies When evaluating research-grade material, it is necessary to distinguish For a specific analyzed batch, CoA can, for example, state: Similarly, the quantitative result, for example analytically determined The dominant chromatographic peak may indicate a high proportion of the main component. Identity, chromatographic purity, quantity and stability are represented The product is available in three quantity variants:<\/p>\n The desired variant can be selected directly at the top of the product page. Results of published research on the molecule Retatrutide and results When evaluating a particular material, the following are particularly relevant:<\/p>\n Store the material in its original, properly sealed and labeled container Protect the product from direct light, moisture, and strong vibrations. The product is available in variants 4 mg, 10 mg and 20 mg<\/strong>. Retatrutide is a synthetic peptide research material known The CAS number of Retatrutide is 2381089-83-2<\/strong>.<\/p>\n Analytical purity must be assessed according to the Certificate of Analysis No. The dominant chromatographic peak can describe a high proportion. The product is intended exclusively for scientific, analytical and laboratory use. No. The product is not intended for human or veterinary use, Retatrutide 4 mg \/ 10 mg \/ 20 mg<\/strong> it is synthetic Retatrutide, also known by the research designation Exclusively for scientific, analytical and laboratory purposes. \ud83d\udce5 Retatrutide 20mg (COA) <\/a><\/p>\n
\nLY3437943<\/strong>, is a synthetic peptide research material
\navailable in variants 4 mg, 10 mg and 20 mg<\/strong>.<\/p>\n
\nexclusively for scientific, analytical and laboratory work procedures
\nperformed under controlled conditions.<\/p>\n
\nin connection with interaction with the three receptor systems:
\nGIP receptor, GLP-1 receptor and glucagon receptor<\/strong>.<\/p>\n
\nof a preventive, diagnostic or therapeutic effect specific to
\nResearch-grade product.<\/p>\nTechnical specification of Retatrutide<\/h2>\n
\n\n
\n Product name<\/th>\n Retatrutide<\/td>\n<\/tr>\n \n Research designation<\/th>\n LY3437943<\/td>\n<\/tr>\n \n Type of material<\/th>\n Synthetic peptide research material<\/td>\n<\/tr>\n \n CAS number<\/th>\n 2381089-83-2<\/td>\n<\/tr>\n \n Available variants<\/th>\n 4 mg \/ 10 mg \/ 20 mg<\/strong><\/td>\n<\/tr>\n \n Form<\/th>\n Lyophilized powder<\/td>\n<\/tr>\n \n Declared analytical purity<\/th>\n According to the CoA, specific production batch<\/td>\n<\/tr>\n \n The receptor research context<\/th>\n GIP, GLP-1 and glucagon receptor<\/td>\n<\/tr>\n \n Documentation<\/th>\n Certificate of Analysis (CoA) according to specific batch<\/td>\n<\/tr>\n \n Storage<\/th>\n According to the conditions stated on the label and in the documentation of the specific batch<\/td>\n<\/tr>\n \n Determination<\/th>\n Scientific, analytical and laboratory research<\/td>\n<\/tr>\n \n Use in humans or animals<\/th>\n Not intended for human or veterinary use<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n Laboratory research context<\/h2>\n
\nto investigate synthetic peptide material in laboratory models
\nfocused on peptide chemistry, molecular characterization,
\nchromatographic properties and receptor interactions.<\/p>\n
\nby interaction with GIP, GLP-1 and the glucagon receptor system<\/strong>.
\nThese data describe the molecular and research context of the substance.<\/p>\n
\nStudies cannot be automatically interpreted as a characteristic of a specific individual.
\ncommercially available research-grade batch.<\/p>\nAnalytical characterization and specific batch<\/h2>\n
\nchromatographic purity, molecular identity, quantitative determination
\nquantity and stability. These are different analytical parameters.<\/p>\n
\nHPLC area purity 99.62 %<\/strong>. However, such an outcome
\napplies exclusively to the analyzed sample and the respective production batch
\nand it cannot be automatically transferred to all future batches or variants.<\/p>\n
\nThe amount of a specific 10 mg sample applies only to the respective analyzed substance.
\nthe sample and documentation to which the result was issued.<\/p>\nWhat does the dominant HPLC peak mean?<\/h3>\n
\nthe detected signal within the used HPLC method. The dominant signal itself
\nHowever, the peak does not confirm the absolute stability of the material nor the absence thereof
\nall possible degradation products<\/strong>.<\/p>\n
\nseparate analytical questions that need to be evaluated according to the methods used
\nmethod and documentation of the specific batch.<\/p>\nRetatrutide 4 mg, 10 mg and 20 mg<\/h2>\n
\n
\nsites. Analytical data and CoA must always be evaluated according to
\nthe specific production batch and the corresponding product variant.<\/p>\nResearch-grade material and CoA<\/h2>\n
\nThe analyses of a specific research-grade product represent two different things.
\ninformation levels.<\/p>\n\n
Key features<\/h2>\n
\n
Storage<\/h2>\n
\nin packaging in accordance with the conditions specified on the label and in the analysis certificate
\nspecific production batch.<\/p>\n
\ntemperature fluctuations. Documentation always takes precedence when storing.
\nand the indication of the specific batch in addition to the general recommendations.<\/p>\nFrequently asked questions<\/h2>\n
What variants of Retatrutide are available?<\/h3>\n
\nA specific variant can be selected directly on the product page.<\/p>\nWhat is Retatrutide?<\/h3>\n
\nalso under the label LY3437943<\/strong>. In molecular research
\nIt is studied mainly in connection with GIP, GLP-1 and glucagon receptor
\nsystematically.<\/p>\nWhat is the CAS number of Retatrutide?<\/h3>\n
What is the purity of Retatrutide?<\/h3>\n
\nthe specific production batch. If the documentation for the specific batch states
\nfor example, HPLC area purity 99.62 %, this result applies only
\non the respective analyzed sample.<\/p>\nDoes one dominant HPLC peak confirm the stability of the peptide?<\/h3>\n
\nthe main detected signal within the used method, but by itself
\ndoes not confirm absolute stability nor the absence of all possible
\ndegradative products.<\/p>\nWhat is Retatrutide intended for?<\/h3>\n
\nworking procedures carried out under controlled conditions.<\/p>\nIs the product intended for use in humans or animals?<\/h3>\n
\nfor consumption, application, diagnosis, prevention or treatment.<\/p>\nWarning<\/h2>\n
\n\n
\n \u26a0 Warning:<\/strong>
\nThis product is intended exclusively for scientific, analytical
\nfor laboratory purposes. It is not a medicine, a dietary supplement,
\na medical device or a finished preparation intended
\nfor personal use. It is not intended for human or veterinary use.
\nuse, consumption, application, diagnosis, prevention or treatment.
\nThe information on this page describes exclusively technical parameters,
\nanalytical data and experimental research context of the material.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>","protected":false},"excerpt":{"rendered":"
\nresearch-grade peptide material supplied in a form
\nlyophilized powder<\/strong>. The product is available in three
\nQuantity variants: 4 mg, 10 mg and 20 mg<\/strong>.<\/p>\n
\nLY3437943<\/strong>, is studied in molecular research
\nin connection with receptor systems
\nGIP, GLP-1 and glucagon receptor<\/strong>.<\/p>\n\n
\nIt is not intended for human or veterinary use.<\/strong><\/p>\n